I. Research Proposal. 1. Background
|
|
|
- Peregrine Carson
- 10 years ago
- Views:
Transcription
1 Sample CFDR Research Proposal I. Research Proposal 1. Background Diabetes has been described as the the perfect epidemic afflicting an estimated 104 million people worldwide (1). By 2010, this figure is expected to double (2). Diabetes is not only a common chronic disease but it meets all 3 criteria for a public health disorder (3). The goal of the clinical management of all forms of diabetes is to control metabolic abnormalities in order to prevent acute (hyperglycemia and hypoglycemia) and long-term complications (retinopathy, nephropathy, neuropathy and cardiovascular disease) without negatively impacting on quality of life (3). Two landmark studies (4,5) have confirmed that attainment of glycemic control as close to normal as possible is necessary for prevention of long term complications in both type 1 (4) and type 2 (5) diabetes and this requires an intensive approach to management. Nutrition is of utmost importance in intensive management (6) and has often been described as the cornerstone of diabetes care (3). The main focus in the nutritional management of diabetes is to improve glycemic control by balancing food intake with endogenous and /or exogenous insulin levels (7). Historically, there have been several attempts to control the glycemic response to food, particularly carbohydrate-containing foods, including use of very low carbohydrate and starvation diets, artificial sweeteners and pharmacological preparations such as fast acting insulin and inhibitors of carbohydrate absorption (8). One way to classify the glycemic response of various carbohydrate-containing foods is Glycemic Index (GI). This term was first coined by Jenkins to describe the extent that blood glucose rises after a test food in comparison to a reference food, usually white bread (9). Although the concept of the GI has made it easy to predict the glycemic response of predominantly carbohydrate-containing foods, the clinical utility of this concept has been seriously questioned, especially as it pertains to mixed meals (10). As well, there has been concern that patients may misapply the GI concept (10). This concern is similar to the one raised when the Canadian Diabetes Association released the sucrose guidelines in 1992 (11). Dietitians were at first reluctant to teach clients with diabetes how to incorporate the added sugar choices into their meal plan out of concern that they would misapply the information and would lead to a deterioration in metabolic control. A longterm study of free-living adults with type 2 diabetes revealed that this concern was unfounded as metabolic control did not deteriorate (12). Although currently not endorsed by the American Diabetes Association (13), the GI is being advocated by most diabetes and health organizations world wide including the World Health Organization, the Diabetes Nutrition Study Group of the European Association for the Study of Diabetes and the Canadian Diabetes Association (7). The use of the GI in clinical practice, and in particular the use of low GI diets, is being advocated by a joint Food and Agriculture Organization (FAO) and World Health Organization (WHO) Expert Consultation (14). The report of this consultation suggests using the GI as a way to guide food choices and to develop exchange lists. The report also suggests how the GI can be applied to mixed meals or whole diets.
2 Currently, in the management of diabetes, glycemic control is assessed by fasting, pre-meal and long-term blood glucose levels (3). However, post-prandial glycemia should also be considered as it may be an independent risk factor in the development of complications related to diabetes (15-17). As post-prandial glycemia is influenced by both the amount and the source of carbohydrate (7), the Glycemic Index is a very important concept to consider. Furthermore, there is a growing body of scientific evidence, including data from epidemiological (18,19) and clinical studies (20-22) linking low Glycemic Index diets with improved outcomes including decreased risk of development of type 2 diabetes (18,19) and improved metabolic control (20-22) and quality of life (20) in individuals with established diabetes. 2. Objective and Hypothesis Given the growing body of evidence regarding the potential benefits of the Glycemic Index in the prevention and clinical management of diabetes and in view that the GI concept is being advocated by the World Health Organization and the Canadian Diabetes Association, it is important to determine the current practices and perceptions of Canadian dietitians with respect to the use of the Glycemic Index in the nutritional management of individuals with diabetes mellitus. Objective The objective of this study is to determine factors associated with use and non-use of the Glycemic Index concept. The factors to be studied are: perceptions (benefits, barriers, confidence in teaching Glycemic Index); knowledge and sociodemographic and professional characteristics (age, gender, province of work, number of years since graduation, number of clients with diabetes counseled per week). Hypothesis Dietitians who use the Glycemic Index will be more likely to have greater perceived benefits, fewer perceived barriers and greater perceived confidence in teaching the Glycemic Index and higher knowledge scores than non-users of the Glycemic Index. 3. Research Design Study Design A Canada-wide survey using a case-control study design will be employed. Our sampling frame will be all dietitians who are active members of Dietitians of Canada and the Ordre Professionnel des Diététistes du Québec. Methods Our sampling strategy will consist of two parts. Part 1: all dietitians who are active members of Dietitians of Canada (n=4955 members) and the Ordre Professionnel des Diététistes du Québec or OPDQ (n=2000 members) will be contacted. Permission has been requested from the respective associations to contact members (Appendix 1). Student and retired members will be excluded. Members who belong to the respective associations will be sent a post-card (Appendix 2). Via this post-card, dietitians will be asked whether they counsel patients with diabetes and if yes, do they use the Glycemic Index in their teaching. Dietitians who counsel individuals with diabetes and who currently use the Glycemic Index in their practice will comprise the case-group and a 1
3 random sample of those who counsel individuals with diabetes but who do not currently use the GI concept in their practice will comprise the control-group. Part 2: Individuals in the case-group and the control-group will be sent the complete questionnaire along with a consent form (Appendix 3). Incentives will be used in both parts of the sampling strategy to increase the response rate. This will consist of a monetary prize totaling $1, There will be 10 prizes of $50 each offered to winners who return the post-card and 1 prize of $500 to one winner who returns the completed questionnaire. Winners will be notified by mail. Names of winners will be held confidential. Sample Size We estimate that approximately 7000 dietitians will be sent the post-card and that approximately 70% will return it (70% response rate). Among respondents (n=5000), we estimate that 50% will counsel patients with diabetes (n=2500) and that 15% will use the Glycemic Index (n=375). Therefore, a total of about 375 dietitians will comprise the case-group. For each dietitian in the case-group, we require at least 3 dietitians in the control-group (23) for a total of about 1125 dietitians in the control-group. With 375 cases, the minimal detectable odds ratio (relative risk) is 1.85 with 80% power and an alpha level of 0.05 (23). The control group will be selected using stratified random sampling technique according to the percentage of members by province as indicated by the membership profile of Dietitians of Canada. An estimated total sample size of 1500 dietitians will be sent the consent form and complete questionnaire and (Appendix 3). Of these, we estimate that approximately 80% will respond. We will ensure this response rate by contacting non or late responders via a second mailing of the questionnaire. Post-Card Please refer to Appendix 2. The post-card will be used in part 1 of the sampling strategy whereby all dietitians who are active members of Dietitians of Canada and the Ordre Professionnel des Diététistes du Québec will be contacted. The post-card will be translated into french (with back-translation) prior to distribution to dietitians who are membres of OPDQ. The post-card is designed to determine the number of dietitians who counsel individuals with diabetes and whether or not they use the Glycemic Index in their practice. The information provided from these post-cards will be used to form the case and control groups who will then receive the Glycemic Index Survey described on the next page. Glycemic Index Survey Please refer to Appendix 3. The survey is designed to address the predictor variables of interest (described in the next page) and to obtain sociodemographic and professional characteristics data related to the practice of dietitians involved in diabetes nutrition education. These may aid in better understanding and characterizing users from non-users of the Glycemic Index concept. Sociodemographic and professional characteristics variables of importance, which may be potential confounders, include: age, gender, year of graduation, region or province, type of practice, number of individuals with diabetes counseled per week and membership in diabetes associations. These will be important variables to consider in our analyses. The survey consists of 21 questions in total, 4 pages in length and takes approximately 10 minutes to complete. The questionnaire will be translated into french (with back-translation) and pilot tested and validated (face and 2
4 content validity) with a sample of practicing dietitians (n=10; 5 francophone and 5 anglophone) prior to distribution of the final version to the target population. Outcome and Predictor Variables A user of the Glycemic Index concept will be defined as a dietitian who counsels individuals with diabetes and who teaches the Glycemic Index to clients with diabetes mellitus. A non-user will be defined as a dietitian who counsels individuals with diabetes but who does not teach the Glycemic Index to clients with diabetes. Our predictor variables are: percieved barriers to using the GI concept in practice; perceived benefits or utility of using the GI concept in practice, perceived confidence of using the GI concept in practice and knowledge related to the GI concept. Perceived benefits and perceived barriers will be determined via questions # 9 ( 6 items, 4-point ordinal scale) and # 10 ( 9 items, 4-point ordinal scale). The formulation of these questions are based on the Health Belief Model (24). Perceived confidence in teaching the GI concept, will be determined via question # 11 (1 item, 4-point ordinal scale) and is based on Social Cognitive Theory (25). Knowledge pertaining to the GI concept will be determined via question # 8 (6 items, true or false). Statistical Analyses The main analyses will be via logistic regression. Questions on benefits, barriers, confidence and knowledge will be included in a model to identify factors associated with being a user or non-user of the GI concept. Alternatively, the variables for benefits, barriers and knowledge can be converted to quasi-continuous measures by calculating, for each person, the proportion of benefits, barriers and correct responses so identified. For this type of data, an adjusted t-test (where user or non-user is the group) will be carried out using multiple linear regression analyses. Adjustments will be made for sociodemographic and professional characteristics as previously described. Time Line for Study Period Major Activities 0-3 months Pilot testing of survey and distribution of post-cards. 3-4 months Return of post-cards and formation of case and control groups. 4-5 months Preparation and distribution of survey. 5-7 months Return of surveys. 7-9 months Distribution and return of reminder surveys months Data entry and analyses. Preparation and submission of manuscript. 3
5 4. Relevance of the Proposal to Dietetic Practice Optimal glycemic control is essential for the prevention and progression of complications in diabetes. Dietitians should be aware of emerging concepts that can impact on the health status of individuals with diabetes mellitus. This study is therefore congruent with the research priorities of Dietitians of Canada in that Glycemic Index is an emerging concept that will lead to new roles for dietitians in improving the health status of all Canadians, particularly those afflicted with diabetes. Since only about half of Canadian dietitians currently have an address (26), a postal survey will allow us to reach all dietitians and thus enhance the generalizability of our findings. The main limitation of this and all survey studies is the possibility of response bias. By conducting a postal survey and by employing a case-control design, we can better target our population of interest, therefore minimizing response bias and enhancing our ability to generalize our findings to all Canadian dietitians. In addition to obtaining valuable information on what facilitates use of the GI concept, we will also obtain an accurate estimate of prevalence of use which could serve as a benchmark for development of strategies to enhance use of the Glycemic Index concept in practice which, in turn, could be of benefit to individuals with diabetes mellitus. 4
Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.
PLEASE NOTE: This trial has been registered retrospectively. Trial Description Title Investigation of the effect of isomaltulose (PalatinoseTM) on metabolic parameters in subjects with Type 2 Diabetes.
CHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications
CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
THE IMPACT OF USING BLOOD SUGAR HOME MONITORING DEVICE TO CONTROL BLOOD SUGAR LEVEL IN DIABETIC PATIENTS
THE IMPACT OF USING BLOOD SUGAR HOME MONITORING DEVICE TO CONTROL BLOOD SUGAR LEVEL IN DIABETIC PATIENTS Alshammari S., *Al-Jameel N., Al-Johani H, Al-Qahtani A., Al-Hakbani A., Khan A. and Alfaraj S.
Development of a Glycemic Index Database for Dietary Assessment. Sally F. Schakel, Rebecca Schauer, John H. Himes, Lisa Harnack, Nancy Van Heel
Development of a Glycemic Index Database for Dietary Assessment Sally F. Schakel, Rebecca Schauer, John H. Himes, Lisa Harnack, Nancy Van Heel What is glycemic index? Applies only to carbohydrate foods.
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study
DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What
Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours
Strengthening the Pharmacist Skills in Managing Diabetes Practice Based Program 27 Contact Hours Presented by New York State Council of Health system Pharmacists October 18 19, 2013 St. John s University,
Introduction. Pathogenesis of type 2 diabetes
Introduction Type 2 diabetes mellitus (t2dm) is the most prevalent form of diabetes worldwide. It is characterised by high fasting and high postprandial blood glucose concentrations (hyperglycemia). Chronic
Inpatient Treatment of Diabetes
Inpatient Treatment of Diabetes Alan J. Conrad, MD Medical Director Diabetes Services EVP, Physician Alignment Diabetes Symposium November 12, 2015 Objectives Explain Palomar Health goals for inpatient
Carbohydrate Counting. Who chooses what you eat every day? Setting The Stage. Pre-Test. Pre-Test. Eating for Diabetes Made Easier
Carbohydrate Counting Eating for Diabetes Made Easier Kris Williams, MS RD Department of Health Education Kaiser Permanente, Kern County Setting The Stage Who chooses what you eat every day? Pre-Test.
DR. Trinh Thi Kim Hue
TYPE 2 DIABETES IN THE CHILD AND ADOLESCENT DR. Trinh Thi Kim Hue CONTENTS Definition Diagnosis Treatment Comorbidities and Complications Comorbidities and Complications Screening for T2D References DEFINITION
BACKGROUND. ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes
BACKGROUND More than 25% of people with diabetes take insulin ADA and the European Association recently issued a consensus algorithm for management of type 2 diabetes Insulin identified as the most effective
Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Support Supplement
CLINICALLY T E S T E D Natural Blood Sugar Metabolic Syndrome with Prediabetic Factors Clinical Study Summary Concerning the Efficacy of the GC Control Natural Blood Sugar Metabolic Syndrome with Prediabetic
DIABETES A chronic, debilitating and often deadly disease A global epidemic Diabetes in Africa
DIABETES A chronic, debilitating and often deadly disease Diabetes is a chronic condition that arises when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin
Competency 1 Describe the role of epidemiology in public health
The Northwest Center for Public Health Practice (NWCPHP) has developed competency-based epidemiology training materials for public health professionals in practice. Epidemiology is broadly accepted as
Monitoring and Carbohydrate Counting: The Cornerstones of Diabetes Control. Linda Macdonald, M.D. November 19, 2008
Monitoring and Carbohydrate Counting: The Cornerstones of Diabetes Control Linda Macdonald, M.D. November 19, 2008 Objectives Understand the relationship between insulin, carbohydrate intake, and blood
Learning Objectives. ADA Diet vs. Medical Nutrition Therapy. In Diabetes, Food IS Medicine: Current Trends In Diabetes Nutrition Management
In Diabetes, Food IS Medicine: Current Trends In Diabetes Nutrition Management Laurel Najarian RD, CDE, M.ED Learning Objectives 1. Discuss the rationale and importance for the use of carbohydrate counting
Baskets of Care Diabetes Subcommittee
Baskets of Care Diabetes Subcommittee Disclaimer: This background information is not intended to be a comprehensive scientific discussion of the topic, but rather an attempt to provide a baseline level
University of Michigan Dearborn Graduate Psychology Assessment Program
University of Michigan Dearborn Graduate Psychology Assessment Program Graduate Clinical Health Psychology Program Goals 1 Psychotherapy Skills Acquisition: To train students in the skills and knowledge
Management of Diabetes in the Elderly. Sylvia Shamanna Internal Medicine (R1)
Management of Diabetes in the Elderly Sylvia Shamanna Internal Medicine (R1) Case 74 year old female with frontal temporal lobe dementia admitted for prolonged delirium and frequent falls (usually in the
A prospective study on drug utilization pattern of anti-diabetic drugs in rural areas of Islampur, India
Available online at www.scholarsresearchlibrary.com Scholars Research Library Der Pharmacia Lettre, 2015, 7 (5):33-37 (http://scholarsresearchlibrary.com/archive.html) ISSN 0975-5071 USA CODEN: DPLEB4
Gayle Curto, RN, BSN, CDE Clinical Coordinator
Gayle Curto, RN, BSN, CDE Clinical Coordinator INTRODUCTION Historical Program Overview Leadership Team Mission Statement Diabetes Center Demographics for 2011 Older Adult Population HISTORICAL PROGRAM
Abdulaziz Al-Subaie. Anfal Al-Shalwi
Abdulaziz Al-Subaie Anfal Al-Shalwi Introduction what is diabetes mellitus? A chronic metabolic disorder characterized by high blood glucose level caused by insulin deficiency and sometimes accompanied
Eating Guidelines for Diabetes
Eating Guidleines Chronic Nutrition Fact Sheets Introduction If you have both diabetes and Chronic (CKD), it may seem that the diabetes and kidney diets don t fit well together. However, with careful planning,
Knowledge of diabetes mellitus amongst nursing students Effect of an intervention
Knowledge of diabetes mellitus amongst nursing students Effect of an intervention Sukhpal Kaur, Indarjit Walia Abstract : Nurses are the key providers of diabetes care. However the information provided
Module I October 18-22, 2015 JW Marriott Marquis Hotel, Dubai, UAE
CME Accreditation is under process Module 1: Diabetes Facts and Diabetes in the Clinic Module 2: Nursing theory and educational (pedagogical) tools to advise and educate people with diabetes and their
Kansas Behavioral Health Risk Bulletin
Kansas Behavioral Health Risk Bulletin Kansas Department of Health and Environment November 7, 1995 Bureau of Chronic Disease and Health Promotion Vol. 1 No. 12 Diabetes Mellitus in Kansas Diabetes mellitus
Algorithms for Glycemic Management of Type 2 Diabetes
KENTUCKY DIABETES NETWORK, INC. Algorithms for Glycemic Management of Type 2 Diabetes The Diabetes Care Algorithms for Type 2 Diabetes included within this document are taken from the American Association
Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
International Diabetes Federation Diabetes Background Information Diabetes mellitus is a chronic condition that occurs as a result of problems with the production and/or action of insulin in the body.
Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
How To Determine The Prevalence Of Microalbuminuria
Research Journal of Pharmaceutical, Biological and Chemical Sciences Prevalence of Microalbuminuria in relation to HbA1c among known Type2 Diabetic Patients in Puducherry population Muraliswaran P 1 *,
CME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus
CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing
Saskatchewan Insulin Adjustment Module Page 2 May 2010
Saskatchewan Insulin Adjustment Module Page 2 Saskatchewan Insulin Adjustment Module Page 3 TABLE OF CONENTS Introduction... 5 Development Background... 5 Purpose... 5 Developing The Policies, Procedures
Diabetes Brief. Pre diabetes occurs when glucose levels are elevated in the blood, but are not as high as someone who has diabetes.
Diabetes Brief What is Diabetes? Diabetes mellitus is a disease of abnormal carbohydrate metabolism in which the level of blood glucose, or blood sugar, is above normal. The disease occurs when the body
Improving drug prescription in elderly diabetic patients. FRANCESC FORMIGA Hospital Universitari de Bellvitge
Improving drug prescription in elderly diabetic patients FRANCESC FORMIGA Hospital Universitari de Bellvitge High prevalence, but also increases the incidence. The older the patients, the higher the percentages
Challenges in Glycemic Control in Adult and Geriatric Patients. Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner
Challenges in Glycemic Control in Adult and Geriatric Patients Denyse Gallagher, APRN-BC, CDE Endocrinology Nurse Practitioner Provide an overview of diabetes prevalence; discuss challenges and barriers
Deakin Research Online
Deakin Research Online This is the published version: Cameron, Adrian J., Shaw, J.E. and Zimmet, P.Z. 2003, Diabetes, in Diabetes and kidney disease : time to act, nternational Diabetes Federation, Brussels,
ESC/EASD Pocket Guidelines Diabetes, pre-diabetes and cardiovascular disease
Diabetes, prediabetes and cardiovascular disease Classes of recommendations Levels of evidence Recommended treatment targets for patients with diabetes and CAD Definition, classification and screening
FACTORS ASSOCIATED WITH HEALTHCARE COSTS AMONG ELDERLY PATIENTS WITH DIABETIC NEUROPATHY
FACTORS ASSOCIATED WITH HEALTHCARE COSTS AMONG ELDERLY PATIENTS WITH DIABETIC NEUROPATHY Luke Boulanger, MA, MBA 1, Yang Zhao, PhD 2, Yanjun Bao, PhD 1, Cassie Cai, MS, MSPH 1, Wenyu Ye, PhD 2, Mason W
DIABETES MELLITUS. By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria
DIABETES MELLITUS By Tracey Steenkamp Biokineticist at the Institute for Sport Research, University of Pretoria What is Diabetes Diabetes Mellitus (commonly referred to as diabetes ) is a chronic medical
Diabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.
Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years
The Burden Of Diabetes And The Promise Of Biomedical Research
The Burden Of Diabetes And The Promise Of Biomedical Research Presented by John Anderson, MD Incoming Chair, ADA s National Advocacy Committee; Frist Clinic, Nashville, TN Type 1 Diabetes Usually diagnosed
ETIOLOGIC CLASSIFICATION. Type I diabetes Type II diabetes
DIABETES MELLITUS DEFINITION It is a common, chronic, metabolic syndrome characterized by hyperglycemia as a cardinal biochemical feature. Resulting from absolute lack of insulin. Abnormal metabolism of
McGill University School of Dietetics and Human Nutrition Graduate Diploma in R.D. Credentialing
McGill University School of Dietetics and Human Nutrition Graduate Diploma in R.D. Credentialing In the School of Dietetics and Human Nutrition at McGill, students with a B.Sc. from outside of Quebec may
MEDICAL POLICY POLICY TITLE DIABETIC SELF-MANAGEMENT TRAINING PROGRAM POLICY NUMBER MP- 2.076
Original Issue Date (Created): July 1, 2005 Most Recent Review Date (Revised): Effective Date: May 24, 2011 August 31, 2011- RETIRED I. POLICY Initial diabetic self-management training (DSMT) may be considered
嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
Study Design and Statistical Analysis
Study Design and Statistical Analysis Anny H Xiang, PhD Department of Preventive Medicine University of Southern California Outline Designing Clinical Research Studies Statistical Data Analysis Designing
2. What Should Advocates Know About Diabetes? O
2. What Should Advocates Know About Diabetes? O ften a school district s failure to properly address the needs of a student with diabetes is due not to bad faith, but to ignorance or a lack of accurate
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY. Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU
TYPE 2 DIABETES IN CHILDREN DIAGNOSIS AND THERAPY Ines Guttmann- Bauman MD Clinical Associate Professor, Division of Pediatric Endocrinology, OHSU Objectives: 1. To discuss epidemiology and presentation
WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES?
Christian In better control with his pump since 2012 WHAT CAN I DO TO REDUCE MY RISK OF DEVELOPING THE COMPLICATIONS OF TYPE 1 DIABETES? Many people with Type 1 diabetes worry about potential long-term
INTERNATIONAL DIABETES CENTER A LEADER IN DIABETES INNOVATION, EDUCATION AND RESEARCH
INTERNATIONAL DIABETES CENTER A LEADER IN DIABETES INNOVATION, EDUCATION AND RESEARCH FACING THE DIABETES EPIDEMIC Diabetes affects more than 280 million people worldwide. That number is expected to reach
Diabetes Mellitus. Melissa Meredith M.D. Diabetes Mellitus
Melissa Meredith M.D. Diabetes mellitus is a group of metabolic diseases characterized by high blood glucose resulting from defects in insulin secretion, insulin action, or both Diabetes is a chronic,
Section 5: Type 2 Diabetes
SECTION OVERVIEW Definition and Symptoms Blood Glucose Monitoring Healthy Eating Physical Activity Oral Medication Insulin Sharps Disposal Definition and Symptoms Type 2 diabetes is occurring more frequently
2013 Diabetes and Eye Disease Fact Sheet
The Georgia Department of Public Health 2013 Diabetes and Eye Disease Fact Sheet Diabetes is the leading cause of new cases of blindness among United States adults. 1-3 As Georgia s population ages and
Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care
Measure #1 (NQF 0059): Diabetes: Hemoglobin A1c Poor Control National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY DESCRIPTION: Percentage
Chapter 8 - General Discussion
Chapter 8 - General Discussion 101 As stated in the introduction, the goal of type 2 diabetes care is to offer patients an integrated set of interventions in relation to life style, blood pressure regulation,
High Blood Pressure and Chronic Kidney Disease
High Blood Pressure and Chronic Kidney Disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney
Personalized Therapy Algorithms for Type 2 Diabetes: A Phenotypization-based Approach
Personalized Therapy Algorithms for Type 2 Diabetes: A Phenotypization-based Approach Riccardo Candido on behalf of the Personalized Therapy AMD Study Group Diabetes Canter A.S.S. 1 Triestina, Italy BACKGROUND
Disability Evaluation Under Social Security
Disability Evaluation Under Social Security Revised Medical Criteria for Evaluating Endocrine Disorders Effective June 7, 2011 Why a Revision? Social Security revisions reflect: SSA s adjudicative experience.
WHAT DOES DYSMETABOLIC SYNDROME MEAN?
! WHAT DOES DYSMETABOLIC SYNDROME MEAN? Dysmetabolic syndrome (also referred to as syndrome X, insulin resistance syndrome, and metabolic syndrome ) is a condition in which a group of risk factors for
Are you ready to pump?
The decision to use an insulin pump is not an easy one. There is a lot involved with managing diabetes using a pump. Take some time to make this decision. Talk about it with your family and your health
EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS
EXPLORING THE INTERACTION BETWEEN EXERCISE AND MEDICATION FOR CHRONIC DISEASE: CONSIDERATIONS FOR FITNESS PROFESSIONALS Steven T. Johnson, PhD 1 Introduction The prevalence of chronic diseases like cardiovascular
Professional Standards For Dietitians In Canada
Professional Standards For Dietitians In Canada Developed by: Dietitians of Canada College of Dietitians of Ontario in collaboration and with financial support from: British Columbia Dietitians' and Nutritionists'
Part B: 3 3. DIABETES MELLITUS. 3.1.1 Effects of diabetes on driving. 3.1.2 Evidence of crash risk. 3.2.1 Hypoglycaemia
3. DIABETES MELLITUS Refer also to section 6 Neurological conditions, section 2 Cardiovascular conditions, section 8 Sleep disorders section 10 Vision eye disorders. 3.1 Relevance to the driving task 3.1.1
Evaluating the Effectiveness of Physician and Clinical Pharmacist Patient Education and Disease Management in Diabetes Mellitus
Evaluating the Effectiveness of Physician and Clinical Pharmacist Patient Education and Disease Management in Diabetes Mellitus Sotheavy Vann Jackson-Hinds Comprehensive Health Center Jackson, MS Introduction
6.4 Diabetes. 6 Priority diseases and reasons for inclusion. Background. Developments since 2004. See Background Paper 6.4 (BP6_4DM.
6 Priority diseases and reasons for inclusion 6.4 Diabetes See Background Paper 6.4 (BP6_4DM.pdf) Background Diabetes and diabetes-related illnesses place an enormous burden on the health care systems
Guide to Biostatistics
MedPage Tools Guide to Biostatistics Study Designs Here is a compilation of important epidemiologic and common biostatistical terms used in medical research. You can use it as a reference guide when reading
Updates for your practice March, 2013. Vol 2, Issue 14 TLALELETSO. Managing Complicated Diabetes
dates for your practice March, 2013. Vol 2, Issue 14 TLALELETSO Managing Complicated Diabetes Diabetes is increasingly common Managing diabetes and working as part of a multidisciplinary team is essential
Diabetes. C:\Documents and Settings\wiscs\Local Settings\Temp\Diabetes May02revised.doc Page 1 of 12
Diabetes Introduction The attached paper is adapted from the initial background paper on Diabetes presented to the Capital and Coast District Health Board Community and Public Health Advisory Committee
1.00 REGULATORY AUTHORITY
ARKANSAS DEPARTMENT OF EDUCATION AND ARKANSAS STATE BOARD OF NURSING RULES GOVERNING THE ADMINISTRATION OF INSULIN AND GLUCAGON TO ARKANSAS PUBLIC SCHOOL STUDENTS SUFFERING FROM DIAGNOSED WITH DIABETES
Using a Flow Sheet to Improve Performance in Treatment of Elderly Patients With Type 2 Diabetes
Special Series: AAFP Award-winning Research Papers Vol. 31, No. 5 331 Using a Flow Sheet to Improve Performance in Treatment of Elderly Patients With Type 2 Diabetes Gary Ruoff, MD; Lynn S. Gray, MD, MPH
Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:
Effects of macronutrients on insulin resistance and insulin requirements
Effects of macronutrients on insulin resistance and insulin requirements Dr Duane Mellor RD Assistant Professor in Dietetics, The University of Nottingham, UK Outline of Discussion Issues of determining
Nutrition Therapy in Diabetes Mellitus. Dorothy Debrah Diabetes Specialist Dietitian University Hospital, Llandough. Wales, UK February 2012
Nutrition Therapy in Diabetes Mellitus. Dorothy Debrah Diabetes Specialist Dietitian University Hospital, Llandough. Wales, UK February 2012 University Hospital Llandough DIABETES MELLITUS. Definition:
How To Manage Diabetes In School
Diabetes is one of the most common chronic diseases in school-aged children, affecting about 208,000 young people in the United States. According to recent estimates, about 23,500 youths are diagnosed
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY. 12a. FOCUS ON Your Risk for Diabetes. Copyright 2011 Pearson Education, Inc.
PowerPoint Lecture Outlines prepared by Dr. Lana Zinger, QCC CUNY 12a FOCUS ON Your Risk for Diabetes Your Risk for Diabetes! Since 1980,Diabetes has increased by 50 %. Diabetes has increased by 70 percent
Administration Manual Pediatric Insulin Pump Program (PIPP) Policies and Procedures Version 2.0
Administration Manual Pediatric Insulin Pump Program (PIPP) Policies and Procedures Version 2.0 Health October 2012 2 Table of Contents SECTION 1: INTRODUCTION... 4 SECTION 2: ROLES AND RESPONSIBILITIES...
What impacts blood glucose levels?
What you eat and how much you eat has an impact on your blood glucose levels. Your blood glucose level reflects how well your diabetes is controlled. There are many aspects to eating for target BG (Blood
